About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD24.96
- USD25.91
- USD24.60
- USD44.32
- -16.80%
- 219M
- 1.66M
- 2.08M
- 4.7B
- 21.62
- -6.00%
Stock News
yesterday
End-of-life decisions can be impossibly hard. But the right senior-care team can make things a little easier.
MarketWatch
yesterday
Oil-Dri Of America (ODC) Q4 2024 Earnings Call Transcript
Yahoo
yesterday
We're raising our price target on Honeywell and adding another stock to the Bullpen
CNBC
yesterday
Tesla suffers $74bn hit after unveiling car with no steering wheel
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
